Biopharma firm Suven Life Sciences has been granted one patent each in 5 nations, including China and Israel, for a drug used in the treatment of neurodegenerative diseases.
Neurodegenerative diseases include Alzheimer's, Schizophrenia and Parkinson's.
In a BSE filing, the company said it has been granted "one product patent from China, one product patent from Israel, one product patent from Mexico, one product patent from Singapore and one product patent from Sri Lanka corresponding to their New Chemical Entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases."
With this development, Suven Life Sciences' total count of patents stands at 17 from China, 20 from Mexico, 21 from Singapore, 11 from Sri Lanka and 7 from Israel.
By PTI | 10 Sep, 2015, 12.15PM IST
Neurodegenerative diseases include Alzheimer's, Schizophrenia and Parkinson's.
In a BSE filing, the company said it has been granted "one product patent from China, one product patent from Israel, one product patent from Mexico, one product patent from Singapore and one product patent from Sri Lanka corresponding to their New Chemical Entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases."
With this development, Suven Life Sciences' total count of patents stands at 17 from China, 20 from Mexico, 21 from Singapore, 11 from Sri Lanka and 7 from Israel.
By PTI | 10 Sep, 2015, 12.15PM IST
Tags:
News